Microbiome Labs Launches DigestMate, a 2-in-1 Digestive Enzyme and Probiotic Formula
Franklinton, North Carolina--(Newsfile Corp. - December 3, 2025) - Microbiome Labs, a leader in microbiome-based solutions, today announced the launch of DigestMate™, a 2-in-1 digestive enzyme and probiotic formula. Digestive health challenges are on the rise in America, impacting millions of lives and driving demand for innovative solutions. According to recent data from the Centers for Disease Control and Prevention (CDC) and the National Institute of Diabetes and Digestive and
2025-12-03 11:44 AM EST | Microbiome Labs
BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product
British Columbia and Rehovot, Israel--(Newsfile Corp. - December 3, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company pioneering its patented Botanical Synthesis technology platform, announces the U.S. launch of VINIA Blood Flow Hydration™, the first hydration solution powered by the blood flow
Biotechnology, Pharmaceuticals, Health
2025-12-03 7:30 AM EST | BioHarvest Sciences Inc.
Cosmo Announces Breakthrough Phase III Topline Results from Scalp 1 and Scalp 2 for Clascoterone 5% Solution in Male Hair Loss, Showing up to 539% Relative Improvement in Target-Area Hair Count vs Placebo; US and EU Submissions are Underway
Ad hoc announcement pursuant to Art. 53 LR 1,465 patients were randomized into the two identical-in-design clinical studies Scalp 1 (NCT05910450) and Scalp 2 (NCT05914805) Both studies reached statistically significant endpoints in TAHC (Target-Area Hair Count), with one reaching 539% relative improvement to placebo and the second study reaching 168% relative improvement to placebo Positive safety profile demonstrated
Healthcare and Hospitals, Health
2025-12-03 1:12 AM EST | Cosmo Pharmaceuticals N.V.
TempraMed Signs Exclusive Commercial Distribution Agreement with Leading Distributor to the Turkish Market
Dolfin is a well-established, diversified distributor with broad reach across healthcare, hospitals, emergency services, and consumers provides strong potential for VIVI products to gain traction Turkey is one of the highest-prevalence diabetes countries in Europe due to obesity rates, diet, urbanization, and low screening compliance One of many distribution agreements in pipeline for Europe as part of TempraMed's def
Technology, Biotechnology, Pharmaceuticals, Health
2025-12-02 5:00 PM EST | TempraMed Technologies Ltd
DiagnosTear Announces Clinical Study with AlyaTec to Advance Analytical Validation and FDA Submission Pathway of TeaRx(TM) Red Eye Diagnostic Test
Vancouver, British Columbia--(Newsfile Corp. - December 2, 2025) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), a fast-growing innovator in point-of-care ocular diagnostics, is pleased to announce a collaboration with AlyaTec, a globally renowned Contract Research Organization (CRO), specializing in allergy and environmental diseases, to initiate a clinical study of TeaRx™ Red Eye in order to advance the global commercialization of
2025-12-02 5:00 PM EST | DiagnosTear Technologies Inc.
Promino Resumes Trading and Achieves Record Sales Growth Through October 2025
Burlington, Ontario--(Newsfile Corp. - December 2, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTCID: MUSLF) (FSE: 93X) ("Promino" or the "Company") is pleased to announce the resumption of trading on the Canadian Securities Exchange effective today. The trading halt, in effect since May 8, 2025, has been lifted following the filing of Promino's 2024 audited financial statements, Management's Discussion and Analysis and related officer certifications, as well as all current interi
Food / Beverages, Sports, Health
2025-12-02 10:35 AM EST | Promino Nutritional Sciences, Inc.
Hemostemix to Attend DFCon San Antonio and Closed its Private Placement
Calgary, Alberta--(Newsfile Corp. - December 2, 2025) - Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is proud to announce its participation in DFCon 2025, hosted by the American Limb Preservation Society in San Antonio, Texas - the global epicentre for innovation in diabetic foot care, vascular medicine, and limb preservation. With more than 500 delegates expected, DFCon gathers the widest spectrum of professionals shaping the future of diabetic limb salvage: podiatrists, vascular surgeo
Biotechnology, Pharmaceuticals, Health
2025-12-02 9:10 AM EST | Hemostemix Inc.
St. Baldrick's Launches Giving Tuesday Campaign to Raise $75,000 for Childhood Cancer Research
Los Angeles, California--(Newsfile Corp. - December 2, 2025) - This Giving Tuesday the St. Baldrick's Foundation, the largest charity funder of childhood cancer research grants in the U.S., invites communities across the country to join the fight against childhood cancer. With a goal of raising $75,000, the campaign will support pioneering research that gives kids battling cancer a chance at a healthy, hopeful life — because
2025-12-02 9:00 AM EST | St. Baldrick's Foundation
Functional Brands Inc. Announces P2i(TM) by Kirkman(R) as the World's First Prenatal Supplement to Fully Align with FIGO's Transparency Standards - and the First to Comply with California's New SB 646 QR-Code Disclosure Law
Lake Oswego, Oregon--(Newsfile Corp. - December 2, 2025) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced that P2i™ by Kirkman® Prenatal Multivitamin & Multimineral is the first prenatal supplement in the world to align its testing and transparency practices with the International Federation of Gynecology and Obstetrics (FIGO) position statement on toxic chemicals and environmental contaminants in prenatal vitami
Household / Consumer / Cosmetics, Health
2025-12-02 8:00 AM EST | Functional Brands Inc.
Aleen Inc. Advances Development of Smart Analytics Feature
Toronto, Ontario--(Newsfile Corp. - December 2, 2025) - Aleen Inc. (CSE: ALEN.U), a digital wellness company, continues its structured path from early exploration and user testing to personal account development, and now moves into full-scale creation of its Smart Analytics feature. Designed to help users interpret their wellness data clearly and responsibly, Smart Analytics transforms raw information into structured, accessible insights. The system emphasizes transparency and personal
2025-12-02 8:00 AM EST | Aleen Inc.
Delota Reports Financial Results for the Three and Six Months Ended September 30, 2025
Highlights: Total revenue of $8.7 million for the Three Months Ended 2026 Total System-Wide Revenue of $10.4 million for the Three Months Ended 2026 31% gross profit margin for the Three Months Ended 2026 Total revenue of $18.7 million for the Six Months Ended 2026 Total System-Wide Revenue of $21.0 million for the Six Months Ended 2026 34% gross prof
Retail, Cannabis, Health, Cannabis Dispensary
2025-12-02 7:30 AM EST | Delota Corp.
Cheelcare to Represent Canadian Health Innovation at Health Tech Forward 2025 in Barcelona
Toronto, Ontario--(Newsfile Corp. - December 2, 2025) - Cheelcare (TSXV: CHER), a Canadian innovator in advanced mobility solutions, was selected to participate in a Canadian trade mission to Barcelona, Spain, from December 2-4, 2025. As part of this mission, Eugene Cherny, CEO of Cheelcare, will present during the "Active Mobility Innovation - Startup Pitches" at the prestigious Health Tech Forward 2025 Conference, showcasing Cheelcare's cutting-edge assistive mobility technology, inc
2025-12-02 7:00 AM EST | Cheelcare Inc.
FendX Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company developing technology-based solutions to reduce the spread of harmful pathogens, announces the completion of its previously disclosed debt settlement from November 21, 2025. The Company issued 34,540 common shares (each, a "Share") at $0.74 per Share to settle $25,560 of debt
Technology, Healthcare and Hospitals, Health
2025-12-01 6:15 PM EST | FendX Technologies Inc.
Numinus Wellness Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, is providing a corporate update. Change of auditors On October 10, 2025, the Company announced that Davidson & Company LLP ("Davidson") had resigned as the Company's i
2025-12-01 5:00 PM EST | Numinus Wellness Inc.
Red Light Holland Reports Second Quarter 2026 Results and Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - December 1, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms, mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal recreational market within the Netherlands, in compliance with all applicable laws, announces its financial and operat
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-12-01 4:30 PM EST | Red Light Holland Corp.
Adia Med Partners with America's #1 Health Talk Show Host, Dr. Asa Andrew, to Bring Breakthrough Stem Cell Therapies to the Spotlight
Winter Park, Florida--(Newsfile Corp. - December 1, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), one of the nation's leaders in Stem Cell Technology is excited to announce a partnership with 3X Physician and Multi-Platform Media talk show personality Dr. Asa Andrew (known to his fans as Doctor Asa).
Healthcare and Hospitals, Health
2025-12-01 9:30 AM EST | Adia Nutrition Inc.
Senior Care Authority Highlights Urgent Need for Proactive Driving-Safety Conversations as Older Driver Awareness Week Begins
Incline Village, Nevada--(Newsfile Corp. - December 1, 2025) - Today marks the start of Older Driver Awareness Week, Dec. 1-5, and Senior Care Authority, a national eldercare consulting and senior living placement company, is encouraging families to begin proactive conversations about driving safety with aging loved ones before a crisis forces the issue. According to
Healthcare and Hospitals, Health
2025-12-01 8:00 AM EST | Senior Care Authority
New Data from the Phase II ARCHER Trial Demonstrate CardiolRx(TM) Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions
Phase II ARCHER trial showed a significant reduction in left ventricular (LV) mass (p=0.0117) and improvements in multiple key cardiac MRI (CMR) measures of structural heart recovery in patients with acute myocarditis. Results provide clinical evidence that CardiolRx™ reduces inflammation-driven structural damage in the heart, an important cause of heart failure progression. The ARCHER data strengthen
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2025-12-01 7:27 AM EST | Cardiol Therapeutics Inc.
Rapid Dose Announces Extension to Promissory Notes
Burlington, Ontario--(Newsfile Corp. - November 28, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that it intends to extend the maturity date of its outstanding secured convertible notes (the "Notes") previously issued on its private placement financing (the "Financing") which closed in 2023. The Notes have a maturity date of November 30, 2025, and the Company intends to extend the maturity date for one year, t
2025-11-28 8:14 PM EST | Rapid Dose Therapeutics Corp.
Promino Nutritional Sciences Inc. Announces Revocation of Cease Trade Order
Burlington, Ontario--(Newsfile Corp. - November 27, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTCID: MUSLF) (FSE: 93X) (the "Company" or "Promino") is pleased to announce the full revocation of a Failure-to-File Cease Trade Order (the "FFCTO") issued by the Ontario Securities Commission (the "OSC") effective on November 26, 2025. The FFCTO prohibited the trading by any person or company of any securities of the Company in Canada, except pursuant to limited exceptio
Food / Beverages, Sports, Health
2025-11-27 2:47 PM EST | Promino Nutritional Sciences, Inc.